Comprehensive screening of Candida auris (Candidozyma auris) to prevent healthcare-associated infections

Candida auris is a globally emerging, multidrug-resistant fungal pathogen that presents unique challenges in identification, treatment, and infection control. Its persistence in healthcare environments, frequent resistance to major antifungals, and ability to cause silent, asymptomatic colonization make early detection through comprehensive screening essential. With increasing endemicity and mandatory reporting in several countries, scientific and clinical communities must prioritize accurate, routine identification to prevent transmission and manage outbreaks effectively.

What you’ll learn:

• How to design and implement an effective C. auris screening protocol in your lab
• Best practices for sample collection, site selection, and risk-based screening
• Tools and technologies for accurate species-level identification and antifungal susceptibility testing
• Guidance on interpreting MIC values in the absence of standardized breakpoints
• Insights into outbreak response: from lab detection to informing IPC strategies
• The latest regulatory updates, including new notifiable organism status and reporting expectations